BPHY-08

N/A

Report date: 2025/02/25 11:17:52
NME

Base Information

Drug NameBPHY-08
Drug Alias NameBPHY-08BPHY08
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein cereblon/E3 ubiquitin-protein ligase ZFP91 degradersCereblon inhibitorsDNA-binding protein Ikaros degraders
TargetsDNA-binding protein IkarosCereblonProtein cereblon/E3 ubiquitin-protein ligase ZFP91
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBiopolar Hongye (Nantong) Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBiopolar Hongye (Nantong) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A